Join me in honoring beloved husband, brother, son and friend, Matt, who we lost far too soon to Myxoid Liposarcoma in May 2024. With no cure, and only three lines of systemic treatment options for this subtype (none guaranteed to work), we need additional research and clinical trial options so that no one has to face this devastating disease. 
Thanks to the Race to Cure Sarcoma events, SFA has invested over $20 million in sarcoma research, funding over 200 grants in 12 countries leading to close to 200 total publications, adding to the sarcoma research discourse. This has led to $26 million+ in additional funding, 10+ clinical trials with 5 additional pending, and 2 patents. Your investment in the RTCS events, is an investment in saving lives.